The Effect of Bifidobacterium Lactis and Inulin on Functional Constipation
NCT ID: NCT01913665
Last Updated: 2013-08-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
200 participants
INTERVENTIONAL
2013-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Probiotic Supplementation on Colonic Transit Time and Gastrointestinal Symptoms in Adults With Constipation.
NCT02189707
B. Lactis HN019 for Functional Constipation
NCT01463293
Consumption of Milk Drink and Constipation
NCT02091115
Lcr35 for Children With Functional Constipation
NCT01985867
Effect of an 8-week Bifidobacterium Lactis HN019 Supplementation on Functional Constipation
NCT04231162
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
B.Lactis
children with functional constipation
B.lactis
Inulin
children with functional constipation
Inulin
B.Lactis+ınulin
children with functional constipation
B.Lactis +Inulin
plasebo
children with functional constipation
Placebo
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
B.lactis
Inulin
B.Lactis +Inulin
Placebo
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* below 18 years of age
Exclusion Criteria
* hirschsprung disease,
* celiac disease,
* hypothyroids,
* neurological deficit,
* constipation treatment receiving children will be excluded
4 Years
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Eskisehir Osmangazi University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Makbule Eren
Associate professor
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Makbule Eren, Associate professor
Role: CONTACT
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
not defined yet
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.